1h Free Analyst Time
The cerebral and tissue oximetry devices market is forecasted to grow by USD 96.3 million during 2023-2028, accelerating at a CAGR of 8.08% during the forecast period. The report on the cerebral and tissue oximetry devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing use of cerebral and tissue oximetry devices in cardiac surgical procedures, increase in product approvals, and growing demand for reducing hospital stays.
The cerebral and tissue oximetry devices market is segmented as below:
By Product
- Modular devices
- Handheld devices
By End-user
- Hospitals
- Clinics
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cerebral and tissue oximetry devices market covers the following areas:
- Cerebral and tissue oximetry devices market sizing
- Cerebral and tissue oximetry devices market forecast
- Cerebral and tissue oximetry devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cerebral and tissue oximetry devices market: Artinis Medical Systems, Boston Scientific Corp., Edwards Lifesciences Corp., GE Healthcare Technologies Inc., Hamamatsu Photonics KK, HyperMed Imaging Inc., ISS Inc., Masimo Corp., Medtronic Plc, Moor Instruments Ltd., Nonin Medical Inc., Sotera Health Co., Spectros Medical Devices Inc., Terumo Corp., and ViOptix Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advances in cerebral and tissue oximetry devices."
According to the report, one of the major drivers for this market is the growing use of cerebral and tissue oximetry devices in cardiac surgical procedures.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Artinis Medical Systems
- Boston Scientific Corp.
- Edwards Lifesciences Corp.
- GE Healthcare Technologies Inc.
- Hamamatsu Photonics KK
- HyperMed Imaging Inc.
- ISS Inc.
- Masimo Corp.
- Medtronic Plc
- Moor Instruments Ltd.
- Nonin Medical Inc.
- Sotera Health Co.
- Spectros Medical Devices Inc.
- Terumo Corp.
- ViOptix Inc.
